2024 Q4 Form 10-Q Financial Statement

#000173112224002036 Filed on December 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue $278.3K $124.2K
YoY Change 123.25% 427.03%
Cost Of Revenue $60.95K
YoY Change 64.6%
Gross Profit $63.27K
YoY Change -570.06%
Gross Profit Margin 50.93%
Selling, General & Admin $142.2K $104.2K
YoY Change 13.83% -13.14%
% of Gross Profit 164.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.324K $760.00
YoY Change 72.17% 105.41%
% of Gross Profit 1.2%
Operating Expenses $332.2K $104.1K
YoY Change 64.93% -13.14%
Operating Profit -$53.92K -$40.88K
YoY Change -29.77% -69.35%
Interest Expense -$7.160K
YoY Change -6.04%
% of Operating Profit
Other Income/Expense, Net -$5.161K -$5.210K
YoY Change -28.22% -104.69%
Pretax Income -$45.73K
YoY Change 52.48%
Income Tax
% Of Pretax Income
Net Earnings -$59.08K -$45.73K
YoY Change -29.63% 52.48%
Net Earnings / Revenue -21.23% -36.81%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 37.92M shares 37.92M shares
Diluted Shares Outstanding 37.84M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $238.7K
YoY Change -9.35%
Cash & Equivalents $284.3K $238.7K
Short-Term Investments
Other Short-Term Assets $34.00K $8.200K
YoY Change
Inventory $471.1K $549.3K
Prepaid Expenses
Receivables $57.27K $31.05K
Other Receivables $0.00
Total Short-Term Assets $846.7K $819.0K
YoY Change 10.28% 6.49%
LONG-TERM ASSETS
Property, Plant & Equipment $29.38K $23.48K
YoY Change 21.19% 293.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $661.1K
YoY Change -5.85%
Total Long-Term Assets $682.3K $684.6K
YoY Change -9.91% -3.32%
TOTAL ASSETS
Total Short-Term Assets $846.7K $819.0K
Total Long-Term Assets $682.3K $684.6K
Total Assets $1.529M $1.504M
YoY Change 0.25% 1.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $79.69K $216.6K
YoY Change -71.07% 33.67%
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $70.67K
YoY Change -36.12%
Long-Term Debt Due $20.40K
YoY Change -84.45%
Total Short-Term Liabilities $246.1K $350.6K
YoY Change -42.14% 2.22%
LONG-TERM LIABILITIES
Long-Term Debt $44.43K
YoY Change -33.36%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $37.24K $44.43K
YoY Change -24.82% -66.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $246.1K $350.6K
Total Long-Term Liabilities $37.24K $44.43K
Total Liabilities $283.3K $395.0K
YoY Change -40.33% -16.7%
SHAREHOLDERS EQUITY
Retained Earnings -$10.74M -$10.64M
YoY Change 1.38% 2.92%
Common Stock $11.98M $11.75M
YoY Change 2.93% 3.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.246M $1.109M
YoY Change
Total Liabilities & Shareholders Equity $1.529M $1.504M
YoY Change 0.25% 1.79%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income -$59.08K -$45.73K
YoY Change -29.63% 52.48%
Depreciation, Depletion And Amortization $1.324K $760.00
YoY Change 72.17% 105.41%
Cash From Operating Activities -$110.2K
YoY Change -182.65%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $72.00K
YoY Change -1540.0%
Cash From Investing Activities $72.00K
YoY Change -1540.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 98.03K
YoY Change -499.8%
NET CHANGE
Cash From Operating Activities -110.2K
Cash From Investing Activities 72.00K
Cash From Financing Activities 98.03K
Net Change In Cash 59.86K
YoY Change -42.32%
FREE CASH FLOW
Cash From Operating Activities -$110.2K
Capital Expenditures $0.00
Free Cash Flow -$110.2K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.007
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1059918 usd
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51791
dei Entity Registrant Name
EntityRegistrantName
INNOVATIVE DESIGNS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0465528
dei Entity Address Address Line1
EntityAddressAddressLine1
124 Cherry Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsburgh
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Entity Central Index Key
EntityCentralIndexKey
0001190370
CY2023Q3 ivdn Miscellaneous Income Expense
MiscellaneousIncomeExpense
usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-07-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15223
dei City Area Code
CityAreaCode
412
dei Local Phone Number
LocalPhoneNumber
799-0350
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37924003 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
284342 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238677 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
57272 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31050 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
471078 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
549276 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
34000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8200 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
846692 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
827203 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29384 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23479 usd
CY2024Q3 us-gaap Deposits On Flight Equipment
DepositsOnFlightEquipment
652944 usd
CY2023Q4 us-gaap Deposits On Flight Equipment
DepositsOnFlightEquipment
652944 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
682328 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
676423 usd
CY2024Q3 us-gaap Assets
Assets
1529020 usd
CY2023Q4 us-gaap Assets
Assets
1503626 usd
CY2024Q3 ivdn Credit Cards Current
CreditCardsCurrent
67634 usd
CY2023Q4 ivdn Credit Cards Current
CreditCardsCurrent
71659 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
79694 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
144967 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
98748 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
121938 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
246076 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
338564 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
37239 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
56429 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
37239 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
56429 usd
CY2024Q3 us-gaap Liabilities
Liabilities
283315 usd
CY2023Q4 us-gaap Liabilities
Liabilities
394993 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37839560 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37839560 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36532560 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36532560 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3784 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3653 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11979124 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11741935 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10737203 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10335578 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1245705 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1108633 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1529020 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1503626 usd
CY2024Q3 us-gaap Revenues
Revenues
278279 usd
CY2023Q3 us-gaap Revenues
Revenues
124650 usd
us-gaap Revenues
Revenues
644497 usd
us-gaap Revenues
Revenues
223546 usd
CY2024Q3 ivdn Cost Of Sales
CostOfSales
189978 usd
CY2023Q3 ivdn Cost Of Sales
CostOfSales
76480 usd
ivdn Cost Of Sales
CostOfSales
376362 usd
ivdn Cost Of Sales
CostOfSales
106839 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
142224 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124944 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
348946 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
359917 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
332202 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
201424 usd
us-gaap Operating Expenses
OperatingExpenses
725308 usd
us-gaap Operating Expenses
OperatingExpenses
466756 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-53922 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-76774 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-80811 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-243210 usd
ivdn Miscellaneous Income Expense
MiscellaneousIncomeExpense
-7519 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3837 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6421 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15783 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
17652 usd
CY2024Q3 us-gaap Depreciation
Depreciation
1324 usd
CY2023Q3 us-gaap Depreciation
Depreciation
769 usd
us-gaap Depreciation
Depreciation
3653 usd
us-gaap Depreciation
Depreciation
2306 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5161 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7190 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19436 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12439 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-59083 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83964 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100247 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-255649 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.002
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.002
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.003
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.007
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37839003 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37839003 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36633430 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36633430 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36972827 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36972827 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36153406 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36153406 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1003072 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
110000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5940 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-44730 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-112591 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
947327 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
141000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
10000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
36000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-83964 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1050363 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
108633 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
105920 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
121400 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-63393 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1272560 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
22228 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1304788 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-59082 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1245706 usd
us-gaap Profit Loss
ProfitLoss
-100247 usd
us-gaap Profit Loss
ProfitLoss
-255649 usd
ivdn Stock Issuance For Services
StockIssuanceForServices
121400 usd
ivdn Stock Issuance For Services
StockIssuanceForServices
41940 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3653 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2306 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
7519 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26222 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11121 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-78198 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
92669 usd
us-gaap Increase Decrease In Retail Related Inventories
IncreaseDecreaseInRetailRelatedInventories
28500 usd
us-gaap Increase Decrease In Retail Related Inventories
IncreaseDecreaseInRetailRelatedInventories
-80000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-2700 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4025 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5391 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
113424 usd
us-gaap Increase Decrease In Due To Officers And Stockholders
IncreaseDecreaseInDueToOfficersAndStockholders
-93855 usd
us-gaap Increase Decrease In Due To Officers And Stockholders
IncreaseDecreaseInDueToOfficersAndStockholders
7728 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41507 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99318 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9558 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20593 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
112574 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7519 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9558 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-125648 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
115920 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
261000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
105630 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
19190 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
14880 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
96730 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
140490 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
45665 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-84476 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238677 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
263293 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
284342 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
178817 usd
us-gaap Interest Paid Net
InterestPaidNet
15783 usd
us-gaap Interest Paid Net
InterestPaidNet
9924 usd
ivdn Noncash Financing Activities
NoncashFinancingActivities
121400 usd
ivdn Noncash Financing Activities
NoncashFinancingActivities
41940 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_800_eus-gaap--BasisOfAccounting_zRatSuDnkUJ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1 - <span id="xdx_82F_zq2jpuOZEXGj">BASIS OF PRESENTATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529">In the opinion of management, the accompanying unaudited financial statements contain all adjustments necessary to present fairly Innovative Designs, Inc.’s (the “Company”) financial position as of July 31, 2024, the changes therein for the nine-month periods that ended and the results of operations for the nine-month periods ended July 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529">The condensed financial statements included in the Form 10-Q (the “Form”) are presented in accordance with the requirements of the Form and do not include all of the disclosures required by generally accepted accounting principles in the United States of America. For additional information, reference is made to the Company’s annual report on Form 10-K for the fiscal year ending October 31, 2023. The results of operations for the nine-month period ending July 31, 2024 are not necessarily indicative of operating results for the full year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529">The Company’s unaudited condensed financial statements have been prepared in accordance with GAAP and pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this report, as is permitted by such rules and regulations. Accordingly, these consolidated financial statements should be read in conjunction with the audited financial statements as of and for the year ended October 31, 2023, and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended October 31, 2023, filed with the SEC on February 23, 2024 (the “2023 Annual Report”). The results for any interim period are not necessarily indicative of results for any future period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529">The unaudited condensed financial statements have been prepared on the same basis as the audited financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all adjustments that are necessary to present fairly the Company’s financial position and results of operations for the interim periods presented. The results for the three and nine months ended July 31, 2024, are not necessarily indicative of the results for the year ending October 31, 2024 , or for any future period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529">As of July 31 2024, there have been no material changes in the Company’s significant accounting policies from those that were disclosed in the 2023 annual report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"> </p>
ivdn Negative Cash Flow
NegativeCashFlow
29296 usd
ivdn Operation Activities
OperationActivities
41507 usd
CY2024Q3 ivdn Retained Earning Accumulated Deficit
RetainedEarningAccumulatedDeficit
10707203 usd
CY2024Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
150 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57272 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
65600 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
65600 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
536678 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
471078 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
50000 usd
CY2023Q4 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.060 pure
CY2023Q4 us-gaap Secured Debt
SecuredDebt
100000 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.20
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
47903 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2429443 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2373888 shares
CY2024Q3 ivdn Shipping And Handling Costs
ShippingAndHandlingCosts
34332 usd
CY2023Q3 ivdn Shipping And Handling Costs
ShippingAndHandlingCosts
27070 usd
CY2024Q3 ivdn Deposits On Equipments
DepositsOnEquipments
652944 usd
CY2023Q4 ivdn Deposits On Equipments
DepositsOnEquipments
652944 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0550 pure
ivdn Lease Rou Description
LeaseROUDescription
The Company entered into a lease for office space at the time the Company was formed through June 2022. 
CY2022Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
260000 usd

Files In Submission

Name View Source Status
0001731122-24-002036-index-headers.html Edgar Link pending
0001731122-24-002036-index.html Edgar Link pending
0001731122-24-002036.txt Edgar Link pending
0001731122-24-002036-xbrl.zip Edgar Link pending
e6233_10q.htm Edgar Link pending
e6233_ex31-1.htm Edgar Link pending
e6233_ex31-2.htm Edgar Link pending
e6233_ex32-1.htm Edgar Link pending
e6233_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ivdn-20240731.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ivdn-20240731_cal.xml Edgar Link unprocessable
e6233_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
ivdn-20240731_def.xml Edgar Link unprocessable
ivdn-20240731_lab.xml Edgar Link unprocessable
ivdn-20240731_pre.xml Edgar Link unprocessable